Updated COVID vaccine 71% effective against hospitalization for older adults

Published by: CIDRAP
Published on: January 5, 2024
By Mary Van Beusekom

The estimated effectiveness of the updated COVID-19 vaccine among people aged 60 and older in the Netherlands was 70.7% against hospitalization and 73.3% against intensive care unit (ICU) admission in fall and early winter 2023, according to a study published yesterday in Eurosurveillance.

Researchers at the National Institute for Public Health and the Environment and University Medical Center Utrecht parsed data on hospitalizations with admission dates from October to December to estimate the effectiveness of the XBB.1.5 Pfizer/BioNTech COVID-19 vaccine among recipients of at least one previous vaccination. The study included 2,050 hospitalized adults aged 60 and older, 14.4% of whom had received the 2023 COVID-19 vaccine.

Comments closed

Rwanda

BioNTech aims to start mRNA vaccine output in Rwanda in 2025

Published December 18, 2023

Published by: Reuters
Published on: December 18, 2023

COVID-19 vaccine maker BioNTech (22UAy.DE) aims to start production at its mRNA vaccine factory site in Rwanda in 2025, company officials said on Monday, the first foreign company mRNA vaccine manufacturing site on the continent.

The German company’s first modular factory elements, based on shipping containers, were delivered to the Kigali construction site in March and were then assembled into so-called BioNTainers.

Comments closed

vaccines

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine

Published September 28, 2023

Published by: The Globe and Mail / The Canadian Press
Published on: September 28, 2023

Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

Comments closed

vaccines

US CDC recommends broad use of updated COVID‑19 vaccines

Published September 13, 2023

Published by: Reuters
Published on: September 13, 2023
By Bhanvi Satija and Michael Erman

The U.S. Centers for Disease Control and Prevention director on Tuesday signed off on broad use of updated COVID-19 vaccines approved by the government – covering ages 6 months and up – as the country prepares to start a vaccination campaign within days.

Comments closed

Tag: BioNTech